If you or someone you know is managing diabetes, there is encouraging news: new government programs are expanding access to wearable glucose monitors across the country. Continuous glucose monitoring (CGM) devices are transforming how people manage their blood sugar, and public health initiatives are making these tools available to more individuals, often at little or no cost. For many patients, especially those facing financial barriers, this expanded access can mean better control over diabetes, fewer emergencies, and improved overall health outcomes.

Continuous glucose monitoring systems track blood sugar levels in real time, 24 hours a day. Using a small, discreet sensor worn on the body, they provide a constant flow of information about glucose trends. When levels rise too high or fall too low, the device sends alerts—often directly to a smartphone or reader—so users can take action immediately. These real-time updates allow for proactive diabetes management rather than reactive responses, which can help prevent serious complications.

Public Initiatives Expanding CGM Access

Public health initiatives are recognizing that diabetes management is more effective when patients have access to the right tools. Across the United States, programs supported by state and federal agencies are working to make CGMs available to seniors, Medicare recipients, and others who meet certain eligibility requirements. Medicare, for instance, has updated its coverage guidelines to include a broader range of patients who use insulin or meet specific medical criteria.

These initiatives reflect a growing understanding that real-time glucose monitoring can reduce long-term healthcare costs by preventing hospitalizations and emergency interventions. Studies have shown that individuals using CGMs experience fewer episodes of severe hypoglycemia or hyperglycemia, and their HbA1c levels often improve significantly over time. By investing in wearable glucose monitor programs, governments are aiming not only to improve patient health but also to reduce the economic burden of unmanaged diabetes on the healthcare system.

What Do CGMs Actually Do?

Wearable glucose monitors use advanced sensor technology to measure interstitial fluid glucose levels just beneath the skin. Unlike traditional fingerstick testing, which offers only a snapshot in time, CGMs deliver continuous readings that can be viewed on a connected device. This gives users a detailed picture of how their glucose changes throughout the day and night.

The data collected by CGMs can highlight how food choices, exercise, stress, illness, and medications affect blood sugar. Some devices also allow users to share their glucose data remotely with healthcare providers or family members, enabling more personalized and timely care.

Real-Time Alerts Can Prevent Emergencies

One of the most valuable features of a CGM is its alert system. For someone with diabetes, a sudden drop in blood sugar during sleep or a rapid spike after a meal can be dangerous. CGM alerts provide a safety net by notifying the user as soon as glucose levels move outside the safe range.

For example, if a CGM detects that glucose is falling quickly, it can send a vibration or sound an alarm, prompting the user to consume a fast-acting carbohydrate before symptoms worsen. Similarly, if glucose is climbing, the device may prompt a correction dose of insulin or other actions to bring levels back to target. This real-time feedback can be lifesaving, particularly for people with hypoglycemia unawareness who do not feel the symptoms until their condition becomes severe.

Cost Coverage Through Public Health Programs

Affordability has historically been one of the biggest barriers to CGM adoption. Many people with diabetes, especially those without comprehensive insurance coverage, have found the cost of sensors and transmitters prohibitive. That’s why the expansion of government coverage is so important.

Medicare, Medicaid, and various state-level programs now help cover the cost of CGMs for qualifying individuals. Depending on the program, coverage may include the device itself, ongoing sensor replacements, and even technical support. For many, this means eliminating or drastically reducing out-of-pocket expenses, making continuous glucose monitoring a realistic option for everyday use.

Some states are also piloting initiatives to provide CGMs to low-income residents who are not yet eligible under Medicare or Medicaid. These pilot programs often target individuals with high hospital readmission rates due to diabetes complications, aiming to reduce preventable medical emergencies.

Designed for Everyday Support

CGMs are not just for those with type 1 diabetes—they are also increasingly used by individuals with type 2 diabetes who require insulin therapy or who experience significant glucose fluctuations. By offering constant feedback, CGMs empower users to make informed decisions about diet, physical activity, and medication timing.

For instance, a person might learn that their glucose rises significantly after a certain breakfast food, prompting a change in meal choices. Or they may notice that moderate exercise helps maintain stable glucose for hours afterward. Over time, these insights contribute to better daily control and fewer disruptions caused by blood sugar swings.

Helping Seniors Maintain Independence

For seniors living alone or managing multiple health conditions, CGMs can be a game changer. Older adults may face challenges with frequent fingerstick testing due to vision problems, dexterity issues, or simple forgetfulness. CGMs reduce the burden of testing while providing reassurance that glucose changes will be detected promptly.

Caregivers and family members can also benefit from CGM technology. Many devices allow remote monitoring, meaning loved ones can receive alerts if glucose levels become dangerously high or low. This feature supports safer, more independent living for seniors and offers peace of mind to their support networks.

Determining Eligibility

Eligibility requirements for government coverage of CGMs vary by program and location. In general, individuals who use insulin multiple times a day, have documented hypoglycemia, or meet specific HbA1c thresholds are more likely to qualify. Medicare currently covers CGMs for many patients with type 1 or type 2 diabetes who require intensive insulin therapy.

Those interested should speak with their healthcare provider to determine if they meet the criteria. Providers can help gather the necessary documentation and submit coverage requests to the appropriate agency. It is also worthwhile to check state-specific programs, as eligibility rules and benefits may differ from federal guidelines.

Expanding Access Means Better Outcomes

The growing availability of wearable glucose monitors through government programs represents a major step forward in diabetes care. By removing cost barriers, these initiatives give more people access to the tools they need to take control of their health. Over time, broader CGM adoption is expected to reduce diabetes-related complications, lower healthcare costs, and improve quality of life for millions.

For anyone living with diabetes—or caring for someone who is—now is the time to explore whether you qualify for a CGM through Medicare, Medicaid, or other assistance programs. This technology can provide the insights and safety features needed to manage diabetes effectively and confidently every day.

By